|
1
|
Stewart DJ: Wnt signaling pathway in
non-small cell lung cancer. J Natl Cancer Inst. 106:djt3562014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen X, Meng J, Yue W, Yu J, Yang J, Yao Z
and Zhang L: Fibulin-3 suppresses Wnt/β-catenin signaling and lung
cancer invasion. Carcinogenesis. 35:1707–1716. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pacheco-Pinedo EC and Morrisey EE: Wnt and
Kras signaling-dark siblings in lung cancer. Oncotarget. 2:569–574.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nelson WJ and Nusse R: Convergence of Wnt,
beta-catenin, and cadherin pathways. Science. 303:1483–1487. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wend P, Holland JD, Ziebold U and
Birchmeier W: Wnt signaling in stem and cancer stem cells. Semin
Cell Dev Biol. 21:855–863. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rubin EM, Guo Y, Tu K, Xie J, Zi X and
Hoang BH: Wnt inhibitory factor 1 decreases tumorigenesis and
metastasis in osteosarcoma. Mol Cancer Ther. 9:731–741. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esteller M: Cancer epigenomics: DNA
methylomes and histone-modification maps. Nat Rev Genet. 8:286–298.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu YL, Yang HP, Gong L, Tang CL and Wang
HJ: Hypomethylation effects of curcumin, demethoxycurcumin and
bisdemethoxycurcumin on WIF-1 promoter in non-small cell lung
cancer cell lines. Mol Med Rep. 4:675–679. 2011.PubMed/NCBI
|
|
9
|
Gao Z, Xu Z, Hung MS, Lin YC, Wang T, Gong
M, Zhi X, Jablons DM and You L: Procaine and procainamide inhibit
the Wnt canonical pathway by promoter demethylation of WIF-1 in
lung cancer cells. Oncol Rep. 22:1479–1484. 2009.PubMed/NCBI
|
|
10
|
Travis WD, Brambilla E, Nicholson AG, et
al: WHO Panel: The 2015 World Health Organization classification of
lung tumors: Impact of genetic, clinical and radiologic advances
since the 2004 classification. J Thorac Oncol. 10:1243–1260. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Warth A, Muley T, Meister M, Stenzinger A,
Thomas M, Schirmacher P, Schnabel PA, Budczies J, Hoffmann H and
Weichert W: The novel histologic International Association for the
Study of Lung Cancer/American Thoracic Society/European Respiratory
Society classification system of lung adenocarcinoma is a
stage-independent predictor of survival. J Clin Oncol.
30:1438–1446. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li Q, Hu X, Bai Y, Alattar M, Ma D, Cao Y,
Hao Y, Wang L and Jiang C: The oxidative damage and inflammatory
response induced by lead sulfide nanoparticles in rat lung. Food
Chem Toxicol. 60:213–217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang S, Jiang C, Liu H, Guan Z, Zeng Q,
Zhang C, Lei R, Xia T, Gao H, Yang L, et al: Fluoride-elicited
developmental testicular toxicity in rats: Roles of endoplasmic
reticulum stress and inflammatory response. Toxicol Appl Pharmacol.
271:206–215. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Le PN, McDermott JD and Jimeno A:
Targeting the Wnt pathway in human cancers: Therapeutic targeting
with a focus on OMP-54F28. Pharmacol Ther. 146:1–11. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Surmann-Schmitt C, Sasaki T, Hattori T,
Eitzinger N, Schett G, von der Mark K and Stock M: The Wnt
antagonist Wif-1 interacts with CTGF and inhibits CTGF activity. J
Cell Physiol. 227:2207–2216. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li ZL, Shao SH, Jiao F, Yue Z and Ma Y:
Cyclin D1 regulates lung cancer invasion and metastasis. Sheng Li
Xue Bao. 64:55–61. 2012.(In Chinese). PubMed/NCBI
|
|
17
|
Xu X, Sun PL, Li JZ, Jheon S, Lee CT and
Chung JH: Aberrant Wnt1/β-catenin expression is an independent poor
prognostic marker of non-small cell lung cancer after surgery. J
Thorac Oncol. 6:716–724. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hunter DD, Zhang M, Ferguson JW, Koch M
and Brunken WJ: The extracellular matrix component WIF-1 is
expressed during, and can modulate, retinal development. Mol Cell
Neurosci. 27:477–488. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin YC, You L, Xu Z, et al: Wnt inhibitory
factor-1 gene transfer inhibits melanoma cell growth. Hum Gene
Ther. 18:379–386. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alamgeer M, Peacock CD, Matsui W, Ganju V
and Watkins DN: Cancer stem cells in lung cancer: Evidence and
controversies. Respirology. 18:757–764. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fang Y, Wang L, Zhang Y, Ge C and Xu C:
Wif-1 methylation and β-catenin expression in colorectal serrated
lesions. Zhonghua Bing Li Xue Za Zhi. 43:15–19. 2014.(In Chinese).
PubMed/NCBI
|
|
22
|
Yang TM, Leu SW, Li JM, et al: WIF-1
promoter region hypermethylation as an adjuvant diagnostic marker
for non-small cell lung cancer-related malignant pleural effusions.
J Cancer Res Clin Oncol. 135:919–924. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cadigan KM and Waterman ML: TCF/LEFs and
Wnt signaling in the nucleus. Cold Spring Harb Perspect Biol.
4(pii): a0079062012.PubMed/NCBI
|
|
24
|
Beyer C, Schramm A, Akhmetshina A, et al:
β-catenin is a central mediator of pro-fibrotic Wnt signaling in
systemic sclerosis. Ann Rheum Dis. 71:761–767. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Roberts DM, Pronobis MI, Poulton JS, Kane
EG and Peifer M: Regulation of Wnt signaling by the tumor
suppressor adenomatous polyposis coli does not require the ability
to enter the nucleus or a particular cytoplasmic localization. Mol
Biol Cell. 23:2041–2056. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bányai L, Kerekes K and Patthy L:
Characterization of a Wnt-binding site of the WIF-domain of Wnt
inhibitory factor-1. FEBS Lett. 586:3122–3126. 2012. View Article : Google Scholar : PubMed/NCBI
|
